Diagnostics Pipeline: Cizzle Bio Introduces Test for Earlier Lung Cancer Detection
The CIZ1B biomarker blood-based assay has 95% sensitivity for detecting earliest stage of the cancer
Already a member? Log in here
Emerging Tests-dtet
Diagnostics Pipeline: Xella Health Launches Platform Focused on Women’s Medical Issues
The startup is trying to close the care gap between female and male patients
Already a member? Log in here
Growing Need for Companion Diagnostics is Evident at Drug Discovery Event
The momentum for targeted therapies has downstream implications for clinical laboratories
Already a member? Log in here
Exome Sequencing Improves Diagnosis of Fetal Structural Anomalies
From – Diagnostic Testing & Emerging Technologies
Prenatal diagnostics have evolved from conventional cytogenetic analysis to increasingly chromosomal microarray analysis, within the last…
Already a member? Log in here
Donor-Derived, Cell-Free DNA May Predict Lung Transplant Rejection
From – Diagnostic Testing & Emerging Technologies
Elevated donor-derived, cell-free DNA (ddcfDNA) in the 3 months post-lung transplant can identify clinically silent allograft injury and…
Already a member? Log in here
Calprotectin May Predict Arthritis Relapse
...
Already a member? Log in here
Study Showing PGx Testing Improves Depression Outcomes, Key to Myriad’s Reimbursement Strategy
From – Diagnostic Testing & Emerging Technologies
Pharmacogenomic testing (PGx) provides clinically meaningful improvement in response and remission rates for difficult-to-treat depression patients over standard of care, according to…
Already a member? Log in here
Diagnostics Sector Saw Increased Investment, Exits in 2018
From – Diagnostic Testing & Emerging Technologies
Life science and health care companies had a banner year in 2018, with a record-breaking year for venture capital investment…
Already a member? Log in here
Sequencing Shows Promise in Care of Common Kidney Disease
...
Already a member? Log in here
Cytokines Could Predict Risk of Side Effects From Immunotherapy
From – Diagnostic Testing & Emerging Technologies
Blood-based cytokine markers may help identify cancer patients at greatest risk of developing side effects from immunotherapy treatment, according to…
Already a member? Log in here
Polygenic Risk Score Predicts Drug Efficacy with Schizophrenia
...
Already a member? Log in here
Panel Size Affects Accuracy of Tumor Mutational Burden Calculation
From – Diagnostic Testing & Emerging Technologies
It has the makings of a Hollywood movie. Three recent college grads start a medical testing software company that uses a digital pathology platform, meet with success, and…
Already a member? Log in here
Sequencing-Based Panel May Improve Evaluation of Thyroid Nodules
From – Diagnostic Testing & Emerging Technologies
A genetic test panel can help patients avoid unnecessary diagnostic thyroid surgeries, according to a study published Nov. 8 in…
Already a member? Log in here
